Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
03/29/19	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	192
03/28/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	10
03/26/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	7
03/22/19	EFFECT	Notice of Effectiveness	1
03/22/19	424B3	Prospectus filed pursuant to Rule 424(b)(3)	207
03/20/19	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1
03/19/19	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents expand_more EX-1	10
03/12/19	F-1/A	Registration statement for securities of certain foreign private issuers Documents expand_more EX-23.1	224
03/11/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments	3
03/04/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments	3